Morgan D A, Brodsky I
J Cell Biol. 1985 Feb;100(2):565-73. doi: 10.1083/jcb.100.2.565.
For 18 mo, we derived 18 cell lines from 11 donors with various clinical profiles ranging from normal to leukemic. Suspension cultures were initiated with 1 X 10(6) mononuclear blood cells/ml of nutrient medium containing 10% human serum and 10% lectin-stimulated human lymphocyte conditioned medium. The cultures were monitored weekly by morphological analyses of Wright-Giemsa-stained cell preparations. All successful cultures showed a significant decline in viability during the first 3-4 wk with rate "lymphoid" cells observed in mitosis. Within the next 2 wk, the proliferating cells gave rise to a rapidly expanding population of mononuclear cells. As the cultures expanded, cell morphology became heterogeneous with respect to cell size and nuclear ploidy, with an accumulation of giant multinuclear cells that were suggestive of megakarocytes. Even though the cells did not have the classical morphology of mature platelet-forming megakaryocytes, 90% of the cells within a cell line were positive by direct or indirect immunofluorescence for the platelet membrane glycoproteins IIb and IIIa; for surface markers HLA-Dr and B2-microglobulin; for intracellular platelet-derived growth factor and platelet factor IV; and for membrane affinity or binding with serum platelet-derived growth factor and platelet factor IV. These results suggest that a blood precursor cell, most likely a primitive megakaryoblast, was isolated from the peripheral blood and was provided with an optimal culture environment for sustained growth. These cells did not mature to a more differentiated stage, perhaps owing to regulatory factor deficiencies in this in vitro system. The remarkable frequency of obtaining cell lines with megakaryocyte properties from normal peripheral blood and the capacity of some normal donors to repeatedly yield these cell lines make this cell culture system indeed unique by being selective for putative megakaryocyte precursors.
在18个月的时间里,我们从11名供体中获得了18个细胞系,这些供体具有从正常到白血病的各种临床特征。悬浮培养从每毫升含有10%人血清和10%凝集素刺激的人淋巴细胞条件培养基的营养培养基中接种1×10⁶个单核血细胞开始。每周通过瑞氏-吉姆萨染色细胞涂片的形态学分析对培养物进行监测。所有成功的培养物在最初3 - 4周内活力显著下降,观察到有处于有丝分裂期的“淋巴样”细胞。在接下来的2周内,增殖细胞产生了快速扩增的单核细胞群体。随着培养物的扩增,细胞形态在细胞大小和核倍性方面变得异质化,出现了大量提示巨核细胞的巨型多核细胞。尽管这些细胞不具有成熟血小板生成巨核细胞的典型形态,但一个细胞系中90%的细胞通过直接或间接免疫荧光检测显示血小板膜糖蛋白IIb和IIIa呈阳性;表面标志物HLA - Dr和β₂ - 微球蛋白呈阳性;细胞内血小板衍生生长因子和血小板因子IV呈阳性;以及与血清血小板衍生生长因子和血小板因子IV的膜亲和力或结合呈阳性。这些结果表明,一种血液前体细胞,很可能是原始巨核母细胞,从外周血中分离出来,并被提供了一个用于持续生长的最佳培养环境。这些细胞没有成熟到更分化的阶段,可能是由于这个体外系统中调节因子的缺乏。从正常外周血中获得具有巨核细胞特性的细胞系的显著频率以及一些正常供体反复产生这些细胞系的能力,使得这个细胞培养系统通过对假定的巨核细胞前体具有选择性而确实独一无二。